SCHEMBL24258376

SCHEMBL24258376

C=CCC1=C(C=C)C(C)=NC=CC1=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11069720 0.66
SCHEMBL7932089 0.56
Acetic Acid SCHEMBL657014 0.55 HSD17B10 (0.32)
SCHEMBL11117053 0.55
SCHEMBL16340528 0.53
SCHEMBL7157137 0.53 ALDH1A1 (0.34)
SCHEMBL8954049 0.52 ALDH1A1 (0.31)
SCHEMBL11443331 0.52 CYP3A4 (0.31)
SCHEMBL11124543 0.51
SCHEMBL11335010 0.49 NPSR1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3177612-B1 OPTIONALLY FUSED HETEROCYCLYL-SUBSTITUTED DERIVATIVES OF PYRIMIDINE USEFUL FOR THE TREATMENT OF INFLAMMATORY, METABOLIC, ONCOLOGIC AND AUTOIMMUNE DISEASES NUEVOLUTION AS (DK) 2022-02-23 EP disclosed